Insider Stock Trading History of Mulroy Michael H.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mulroy Michael H. since year 2005. The trader's CIK number is 1509725. At the time of this reporting, Mulroy Michael H. is the President and CEO of Asterias Biotherapeutics, Inc. . (stock ticker symbol ASTY). See this page for all insider trading activities at Asterias Biotherapeutics, Inc. .

Note that in the past Mulroy Michael H. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Mulroy Michael H. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-25 AST Asterias Biotherapeutics, Inc. Buy 1,537 3.25 4,996
2014-08-11 QCOR Questcor Pharmaceuticals Inc Sale 10,000 92.33 923,349
2014-07-10 QCOR Questcor Pharmaceuticals Inc Option Ex 10,000 14.24 142,400
2014-07-10 QCOR Questcor Pharmaceuticals Inc Sale 10,000 90.89 908,910
2014-06-10 QCOR Questcor Pharmaceuticals Inc Option Ex 10,000 14.24 142,400
2014-06-10 QCOR Questcor Pharmaceuticals Inc Sale 10,000 88.57 885,740
2014-05-12 QCOR Questcor Pharmaceuticals Inc Option Ex 10,000 14.24 142,400
2014-05-12 QCOR Questcor Pharmaceuticals Inc Sale 10,000 87.99 879,910
2014-04-10 QCOR Questcor Pharmaceuticals Inc Option Ex 10,000 14.24 142,400
2014-04-10 QCOR Questcor Pharmaceuticals Inc Sale 10,000 85.04 850,400
2014-03-10 QCOR Questcor Pharmaceuticals Inc Sale 10,000 64.86 648,580
2014-03-10 QCOR Questcor Pharmaceuticals Inc Option Ex 10,000 14.24 142,400
2012-05-23 QCOR Questcor Pharmaceuticals Inc Buy 1,000 40.00 40,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mulroy Michael H. (President and CEO of Asterias Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.